Continuous wound infusion with ropivacaine fails to provide adequate analgesia after caesarean section

Kainu, J.P.; Sarvela, J.; Halonen, P.; Puro, Helena; Toivonen, Heikki; Halmesmäki, Erja; Korttila, K.

doi:10.1016/j.ijoa.2011.12.009

Cited by 45 publications

(27 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…And they reported significant analgesic efficacy both in reducing pain scores and opioid use. However, studies have shown that subcutaneous infiltrations may not improve postoperative pain scores, although they do have an impact on opioid consumption [8,9]. When compared with subfascial injection, the deeper infiltration results in better efficacy [10].…”

Section: Discussionmentioning

confidence: 99%

Continuous wound infusion of ropivacaine for the control of pain after thoracolumbar spinal surgery: a randomized clinical trial

Ren

et al. 2015

Eur Spine J

View full text Add to dashboard Cite

Purpose A prospective randomized clinical trial was carried out to observe the analgesic efficacy of ropivacaine for postoperative pain following thoracolumbar spinal surgery. Methods Seventy-one patients with elective posterior thoracolumbar spinal surgery were randomly divided into two groups. Local group received 0.33 % ropivacaine by pump through the wound, and intravenous group received flurbiprofen axetil, pentazocine and palonosetron via intravenous pump. We evaluated the level of pain, the incidence of adverse reactions at 2, 4, 6, 12, 24, 36 and 48 h after operation, and the occurrence of chronic pain 3 months later. Results There were no significant differences in the pain level between the two groups. However, the incidence of nausea, vomiting and chronic pain was significantly lower in the local group. Conclusions Our results showed that local infusion of ropivacaine achieved similar analgesic effects to intravenous delivery of analgesic drugs, but significantly reduced incidence of nausea, vomiting and chronic pain.

show abstract

Section: Discussionmentioning

confidence: 99%

Continuous wound infusion of ropivacaine for the control of pain after thoracolumbar spinal surgery: a randomized clinical trial

Ren

et al. 2015

Eur Spine J

View full text Add to dashboard Cite

show abstract

“…This method was used for more than 15 years, and with the development of the catheters the use of continuous local analgesia has varied, currently being used in the postoperative period in obstetrics for C-section pain control [4], in orthopedics after hip and knee surgery [5], in cardiothoracic surgery after thoracotomy [6], in plastic surgery after mammoplasty [6] and in abdominal surgery after laparotomy [7]. Although the results obtained in many of these fields are favorable, there are also situations where continuous analgesia can be futile, as in inguinal hernias surgery that can be treated in a "day-case procedure" [7].…”

Section: Discussionmentioning

confidence: 99%

Continuous Local Analgesia in Postoperative Treatment of Large Incisional Hernias – Preliminary Results

Gherghinescu

Molnar

Popa

et al. 2015

Acta Medica Marisiensis

View full text Add to dashboard Cite

Background: The incisional hernias are frequent complications after laparotomy. Extended subcutaneous tissue dissection is often necessary for the treatment of large incisional hernias, and this procedure is frequently followed by a high intensity pain in the postoperative period. The aim of this study was to assess the postoperative patient comfort without using major analgesics. Material and method: we present the preliminary results of an ongoing study from Surgery Clinic 1 of Emergency Clinical County Hospital of Târgu Mures, University of Medicine and Pharmacy Târgu Mures. The study comprises in the intraoperative insertion of a subcutaneous catheter (Pajunk InfiltraLong) placed on lay, through which we administered continuously Ropivacaine 0,5%. Results: Ten patients have been included in the study by now. For 5 of the patients the wound infiltration was started with 7 ml/h in the first 6 postoperative hours, after which the rate decreased to 5 ml/h until the end of the 72 hours, when the catheter was removed. For 2 patients the wound infiltration was started with 10ml/h in the first 6 postoperative hours, after which the rate decreased to 7 ml/h in the first day, followed by 5 ml/h for the next two days. Two patients needed a minor analgesic in the immediate postoperative period and one patient needed major analgesia in the first 24 hours. Conclusions: By using this method, postoperative analgesia can be achieved without using major systemic analgesics and a superior patient comfort can be achieved simply by adjusting the infusion rate

show abstract

“…There are two studies[3940] of single shot wound infiltration and four RCTs of continuous wound infusion[41424344] for post-caesarean analgesia [Table 4]. The drug used for infusion/infiltration is LA in six while in one study tramadol infiltration was compared to LA.…”

Section: Wound Infiltration/continuous Wound Infusion With Local Anaementioning

confidence: 99%

“…Most trials found continuous wound infusion to be less effective as compared to placebo[41] or ITM[42] or epidural levobupivacaine[40] whereas one found it to be equally effective to epidural morphine in post-operative analgesic requirement. [43] Rackleboom et al .…”

Section: Wound Infiltration/continuous Wound Infusion With Local Anaementioning

confidence: 99%

Post-caesarean analgesia: What is new?

2017

View full text Add to dashboard Cite

Continuous wound infusion with ropivacaine fails to provide adequate analgesia after caesarean section

Cited by 45 publications

References 23 publications

Continuous wound infusion of ropivacaine for the control of pain after thoracolumbar spinal surgery: a randomized clinical trial

Continuous wound infusion of ropivacaine for the control of pain after thoracolumbar spinal surgery: a randomized clinical trial

Continuous Local Analgesia in Postoperative Treatment of Large Incisional Hernias – Preliminary Results

Post-caesarean analgesia: What is new?

Contact Info

Product

Resources

About